Für diese Kanzlei können nur begrenzte Informationen angezeigt werden. Für die folgenden Kanzleien werden vollständigere Informationen angezeigt:
ZSK Attorneys-at-Law provides ‘expert guidance’ to domestic and multinational clients in the life sciences and healthcare industry, including assistance with licensing agreements, anti-corruption policies, and building compliance systems. Yue Peng directs the group, bringing a wealth of experience advising pharmaceutical and biotech companies on commercialisation, clinical trials, and financing transactions.
Legal 500 redaktioneller Kommentar
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
- 'ZSK Attorneys-at-Law provides expert guidance on a range of matters, including compliance with our China-specific business model, anti-corruption policies, R&D collaborations within the country, sales initiatives, licensing agreements, and other related issues. ZSK is very good at dealing with problems in the field of healthcare, which is why we choose ZSK.''
- 'ZSK has extensive experience and unique insight in the healthcare field, with a focus on compliance in cross-border transactions. They are able to deeply understand our needs, maintain efficient communication, continuously improve transaction documents and carefully handle every aspect of the transaction to achieve excellence.'
Kernmandanten
- ChemPartner PharmaTech Co., Ltd.
- Jiangsu Ascentage Pharma Development Co., Ltd.
Highlight-Mandate
- Advised InxMed on license in of Shi Jian's ADC technology platform EZWi-Fit for the development of ADC products targeting InxMed's biotargets.
- Advised Nanjing Bio-tech and Pharmaceutical Valley on setting up three medical funds.